Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000679415 | SCV000569626 | likely benign | not provided | 2022-05-24 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Center for Human Genetics, |
RCV000660122 | SCV000782112 | uncertain significance | Neurofibromatosis, type 1 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679415 | SCV000806321 | likely benign | not provided | 2016-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000660122 | SCV002472615 | benign | Neurofibromatosis, type 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559124 | SCV005048560 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2014-12-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |